NIBR, the innovation engine of Novartis, has invited iMM to participate in their NIBR Global Scholars Program.
iMM is the first Portuguese institution to participate in this initiative designed to connect innovative thinkers from select academic institutions with Novartis scientific sponsors. Through this, NIBR will support projects focused on novel science that can be translated to drug discovery and/or clinical research. Selected proposals, not funded by traditional grant support, will receive up to $1M over three years, and each selected scholar will join forces with a scientist from Novartis to promote synergies in advancing research into early development stages. Additionally, a dedicated NIBR Alliance Manager will support the successful collaboration projects.
This represents a great opportunity for iMM to strengthen and value the translational research made at the institute along with one of the top international pharmaceutical companies.
For further information click here.